StockData
DBV Technologies S.A. logo

DBV Technologies S.A. (DBVT) stock

DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 6/30
$11.43−0.45 (-3.79%)

Close on Nov 12, 2026Market cap $718.69MP/E –Yield –

DBV Technologies pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

DBV Technologies's pe ratio was 1.9× on Jan 31, 2025, against 0.4× a year earlier. Over the last 2 years it ranged from 0.2× to 1.9×, with a median of 0.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20251.9×+0.5
2024Dec 31, 20241.4×+1.0
2023Dec 29, 20230.4×–

More DBV Technologies figures

See a number that looks wrong?